
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
Author(s) -
Roger S. McIntyre,
Rana Fayyad,
Christine J. Guico-Pabia,
Matthieu Boucher
Publication year - 2015
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.14m01681
Subject(s) - placebo , medicine , hazard ratio , major depressive disorder , proportional hazards model , psychiatry , confidence interval , alternative medicine , pathology , amygdala
To evaluate relapse rates and predictors of relapse in 2 randomized, placebo-controlled trials of desvenlafaxine for major depressive disorder (MDD).